Delivery Order SPE2DB22D2103-SPE2DB25FR9AR
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,040.41 firm fixed price delivery order contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a specialty medication. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,524.36, is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a pharmaceutical product. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,343.35 firm fixed price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,206.66 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML pharmaceutical products. The contract has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a pharmaceutical product, with a ceiling value of $1,358.61. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 26, 2025. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,505.64 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a medication. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,577.04, is for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product. The contract has an ultimate completion date of April 2, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,807.16 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a medication, with a period of performance through March 6, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a $2,060.52 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, through which the company provides a comprehensive range of pharmaceutical products...
This is a $1,550.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product, with a completion date of March 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...